Antibiotic tan-749, its derivatives, production and use thereof
AssigneeTakeda Chemical Industries, Ltd.
InventorsSetsuo Harada, Hideo Ono, Hirotomo Masuya, Hideaki Natsugari
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Chemical Industries, Ltd.
InventorsSetsuo Harada, Hideo Ono, Hirotomo Masuya, Hideaki Natsugari
Estimating the term…
A compound of the formula ##STR1## wherein R.sup.1 and R.sup.4 are independently amino or an organic residue bonded through nitrogen, R.sup.2 is hydrogen or alkyl which may be substituted, R.sup.3 is hydrogen or a protecting group and R5 is hydroxyl which may be substituted or amino which may be substituted or salts thereof; with the proviso that when R.sup.1 is amino, leucylamino, acetylamino or benzyloxycarbonylamino, R.sup.3 is hydrogen, methyl or 2-tettrahydropyranyl, R.sup.4 is amino, acetylamino or benzyloxycarbonylamino and R.sup.5 is hydroxyl which may be substituted or amino which may be substituted, R.sup.2 is alkyl which may be substituted, has antibacterial activities against drug-resistant bacteria and therefore can be useful as a chemotherapeutic drug for bacterial infections in mammals.
A compound of the formula ##STR497## wherein R.sup.1 and R.sup.4 are independently amino or an organic residue bonded through nitrogen, R.sup.2 is hydrogen or alkyl which may be substituted, R.sup.3 is hydrogen or a protecting group and R.sup.5 is hydroxyl which may be substituted or amino which may be substituted;
A compound of the formula ##STR498## wherein R.sup.1 and R.sup.4 are independently amino or an organic residue bonded through nitrogen, R.sup.2 is hydrogen or alkyl which may be substituted, R.sup.3 is hydrogen or a protecting group and R.sup.5 is hydroxyl which may be substituted or amino which may be substituted;
A compound of the formula ##STR499## wherein R.sup.1 is amino, hexanoylamino or 2,4-hexadienoylamino, R.sup.2 is hydrogen or methyl, R.sup.3 is hydrogen, R.sup.4 is an amino which may optionally be protected and R.sup.5 is hydroxyl or 2-amidinoethylamino, with the proviso that when R.sup.1 is amino, R.sup.2 is hydrogen, R.sup.3 is hydrogen and R.sup.4 is amino, R.sup.5 is 2-amidinoethylamino, or a pharmaceutically acceptable salt thereof.
The compound according to calim 2, wherein R.sup.1 is 5-chloro-2,4-pentadienoylamino, R.sup.2 and R.sup.3 are hydrogen, R.sup.4 is amino and R.sup.5 is 2-amidinoethylamino.
The compound according to calim 3, wherein R.sup.5 is 2-amidinoethylamino.
Dependencies are inferred from the claim text.